BioVectra
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
BioVectra is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Canada
Founded:2018
Employees:2,237
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Technology Platforms
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Asia-Pacific
Manufacturing Facilities
1 site worldwide
BioVectra - Canada Facility
Canada
Site Capabilities
Biologics Manufacturing
Monoclonal Antibodies
Vaccines
Regulatory Approvals
Drug Approval ZO89JG
FDA · #APR-UPIRKS71 · 2020-12-01
Customer Reviews
No reviews available yet.
Company Documents
No documents available.
Loading CDMO intelligence...